FDA Authorizes First At-Home Test for Syphilis as Cases Spike

Reported syphilis cases in the United States increased by 80 percent in 2022, according to the CDC.

The U.S. Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times

The U.S. Food and Drug Administration (FDA) on Friday authorized NOWDiagnostic to market the first at-home, over-the-counter test for syphilis amid a rising trend of cases in the United States.

This newly-approved test is designed to detect syphilis antibodies in human blood and will provide results within 15 minutes, according to the regulator.